JPMORGAN EMERGING MARKETS GROWTH & INCOME PLC
(the ‘Company’)
Legal Entity Identifier: 5493001VPQDYH1SSSR77
Information disclosed in accordance with DTR 3.1.2-A, incorporating Article 19(1) of the Market Abuse Regulation
10 November 2026
1. | Details of the person discharging managerial responsibilities / persons closely associated | ||||
a) | Name | Aidan Lisser | |||
2. | Reason for the notification | ||||
a) | Position / Status | Director | |||
b) | Initial notification/ Amendment | Initial Notification | |||
3. | Details of the issuer | ||||
a) | Name | JPMorgan Emerging Markets Growth & Income Plc | |||
b) | Legal Identifier Code | 5493001VPQDYH1SSSR77 | |||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 2.5p each ISIN: GB00BMXWN182 | |||
b) | Nature of the Transaction | Acquisition of shares | |||
c) | Price and Volume | Price | Volume | ||
£1.487897 | 6,750 | ||||
d) | Aggregated information - Aggregated price - Price | N/A single transaction | |||
e) | Date of transaction | 9 November 2026 | |||
f) | Holding post the transaction | 77,350 Ordinary shares | |||
g) | Place of transaction | London Stock Exchange, XLON | |||
For further information:
Anmol Dhillon
JPMorgan Funds Limited
0800 20 40 20 (or +44 1268 44 44 70)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.